Tenax Therapeutics (TENX) Announces Closing of $100 Million Private Placement and Plans to Accelerate the Oral Levosimendan Phase 3 Program Aug 12, 2024 08:07AM
Tenax Therapeutics Announces Closing of $100 Million Private Placement and Plans to Accelerate the Oral Levosimendan Phase 3 Program Aug 12, 2024 08:00AM
Tenax Therapeutics (TENX) Announces $100M Private Placement Aug 6, 2024 07:13AM
Tenax Therapeutics Announces Oversubscribed $100 Million Private Placement Aug 6, 2024 07:13AM
Tenax Therapeutics (TENX) Prices 1.6M Share Offering at $5.65/sh Feb 8, 2024 08:17AM


Feb 8, 2024 08:16AM Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
Feb 3, 2023 08:21AM Tenax Therapeutics (TENX) Prices Prices 8.67M Share Offering at $1.80/sh
Feb 3, 2023 08:19AM Tenax Therapeutics Announces Pricing of Approximately $15.6 Million Public Offering
Sep 15, 2022 08:34AM Tenax Therapeutics (TENX) Announces Evaluation of Strategic Alternatives
Sep 15, 2022 08:30AM Tenax Therapeutics Announces the Evaluation of Strategic Alternatives